Sonoma Pharmaceuticals In... (SNOA)
NASDAQ: SNOA
· Real-Time Price · USD
5.32
0.05 (0.95%)
At close: Aug 15, 2025, 3:59 PM
5.20
-2.26%
After-hours: Aug 15, 2025, 07:58 PM EDT
Sonoma Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
April - March.
Fiscal Year | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Cash & Equivalents | 3.6M | 5.37M | 5.24M | 4.08M | 2.59M | 3.13M | 2.41M | 2.14M | 3.54M | 3.82M | 2.63M | 3.35M | 5.59M | 7.4M | 8.53M | 8.39M | 2.81M | 4.22M | 5.54M | 4.32M | 4.55M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 104K | 147K | 194K | 255K | 544K | 658K | 456K | 496K | 559K | 578K | 822K | 777K | 695K | 707K | 726K | 770K | 869K | 875K | 944K | 874K | 848K |
Receivables | 2.6M | 3.76M | 2.4M | 3.16M | 3.25M | 2.9M | 2.88M | 2.22M | 2.44M | 2.57M | 2.3M | 2.49M | 2.43M | 2.41M | 2.85M | 3.42M | 3M | 2.81M | 4.41M | 5.28M | 5.22M |
Inventory | 3.8M | 2.92M | 3.14M | 2.84M | 2.66M | 2.72M | 2.96M | 2.51M | 2.73M | 2.86M | 2.85M | 3.02M | 2.79M | 2.66M | 2.88M | 2.48M | 2.62M | 2.53M | 2.96M | 3.7M | 4.19M |
Other Current Assets | 3.1M | 360K | 1.6M | 2.15M | 237K | 262K | 4.26M | 4.64M | 4.87M | 240K | 3.45M | 215K | 215K | 218K | 211K | 212K | 219K | 209K | 218K | 194K | 188K |
Total Current Assets | 13.11M | 12.65M | 12.38M | 12.22M | 11.93M | 12.55M | 12.5M | 11.52M | 13.59M | 13.8M | 11.23M | 12.39M | 14.82M | 16.43M | 17.7M | 18.02M | 12.16M | 12.98M | 16.21M | 16.27M | 17.09M |
Property-Plant & Equipment | 837K | 309K | 334K | 417K | 518K | 651K | 738K | 783K | 839K | 906K | 785K | 835K | 787K | 879K | 922K | 1.04M | 1.09M | 1.13M | 1.07M | 1M | 715K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 1.49M | 1.04M | 1.29M | 1.46M | 1.98M | 2.61M | 2.12M | 2.12M | 2.31M | 2.43M | 2.7M | 2.57M | 2.34M | 2.42M | 1.65M | 1.81M | 1.96M | 2M | 2.02M | 1.88M | 1.56M |
Total Assets | 14.59M | 13.69M | 13.67M | 13.69M | 13.67M | 14.89M | 14.62M | 13.63M | 15.89M | 16.23M | 13.93M | 14.96M | 17.16M | 18.84M | 19.35M | 19.83M | 14.12M | 14.99M | 18.23M | 18.14M | 18.65M |
Account Payables | 2.05M | 953K | 1.4M | 770K | 751K | 607K | 864K | 987K | 1.09M | 841K | 1.3M | 1.07M | 2.06M | 1.64M | 1.58M | 1.88M | 1.83M | 1.77M | 2.43M | 3.2M | 4.13M |
Deferred Revenue | 731K | 641K | 302K | 319K | 413K | 478K | 138K | 162K | 162K | 160K | 155K | 153K | 153K | 1.28M | 152K | 153K | 239K | 319K | 204K | 198K | 196K |
Short-Term Debt | 235K | 220K | 90K | 82K | 204K | 323K | 44K | 172K | 534K | 687K | 276K | 511K | 692K | 808K | 848K | 1.06M | 1.96M | 836K | 200K | 237K | 400K |
Other Current Liabilities | 1.84M | 487K | -90K | n/a | n/a | 694K | n/a | n/a | -466K | 310K | -552K | -564K | -466K | 784K | -522K | -552K | -500K | 127K | -400K | -376K | -270K |
Total Current Liabilities | 4.85M | 4.1M | 3.7M | 3.31M | 3.75M | 3.72M | 3.07M | 3.24M | 4.04M | 3.72M | 3.93M | 3.53M | 4.85M | 5.82M | 3.88M | 4.08M | 5.23M | 4.08M | 3.88M | 4.57M | 5.47M |
Long-Term Debt | 440K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15K | 15K | 15K | n/a | n/a | n/a | n/a | 1.31M | 1.31M | 1.31M | 1.31M |
Other Long-Term Liabilities | 5.25M | 5.14M | 5.04M | 4.93M | 4.82M | 4.71M | 4.59M | 4.47M | 4.36M | 4.24M | 4.1M | 4.01M | 3.93M | 3.84M | 3.75M | 3.66M | 3.57M | 3.48M | n/a | n/a | n/a |
Total Long-Term Liabilities | 5.69M | 5.19M | 5.09M | 5.02M | 4.95M | 5.04M | 4.85M | 4.72M | 4.61M | 4.54M | 4.43M | 4.41M | 4.34M | 4.33M | 4.3M | 4.29M | 4.27M | 5.55M | 2.03M | 2.01M | 1.77M |
Total Liabilities | 10.54M | 9.28M | 8.8M | 8.33M | 8.7M | 8.76M | 7.93M | 7.96M | 8.65M | 8.25M | 8.37M | 7.94M | 9.2M | 10.15M | 8.18M | 8.37M | 9.5M | 9.62M | 5.92M | 6.58M | 7.24M |
Total Debt | 675K | 305K | 119K | 244K | 420K | 608K | 385K | 522K | 655K | 849K | 486K | 774K | 952K | 1.37M | 1.21M | 1.49M | 2.43M | 2.67M | 1.98M | 2.02M | 1.93M |
Common Stock | n/a | n/a | n/a | n/a | 2K | 2K | 2K | 1K | 5K | 5K | 2K | 2K | 2K | 2K | 3K | 3K | 2K | 2K | 2K | 2K | 2K |
Retained Earnings | -199.05M | -197.81M | -197.03M | -196.1M | -195.49M | -194.35M | -193.28M | -192.42M | -190.93M | -189.51M | -188.21M | -186.27M | -185.25M | -184.36M | -181.42M | -180.47M | -180.38M | -179.28M | -172.54M | -171.89M | -171.25M |
Comprehensive Income | -3.57M | -4.38M | -4.55M | -4.2M | -3.6M | -2.72M | -2.82M | -3.12M | -2.91M | -3.42M | -4.18M | -4.41M | -4.38M | -4.31M | -4.57M | -4.51M | -4.27M | -4.58M | -4.24M | -5.25M | -5.45M |
Shareholders Equity | 4.06M | 4.41M | 4.87M | 5.35M | 4.97M | 6.14M | 6.69M | 5.67M | 7.24M | 7.98M | 5.56M | 7.02M | 7.96M | 8.7M | 11.17M | 11.46M | 4.62M | 5.36M | 12.32M | 11.56M | 11.41M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |